Review of the clinical applications and technological advances of circulating tumor DNA in cancer monitoring.

Chang, Yi; Tolani, Bhairavi; Nie, Xiuhong; Zhi, Xiuyi; Hu, Mu; He, Biao

Chang, Yi; Tolani, Bhairavi; Nie, Xiuhong; Zhi, Xiuyi; Hu, Mu; He, Biao.

Afiliación

Chang Y; Department of Respiratory Medicine, Xuanwu Hospital, Capital Medical University, Beijing, China.
Tolani B; Thoracic Oncology Program, Department of Surgery, Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, CA, USA.
Nie X; Thoracic Oncology Program, Department of Surgery, Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, CA, USA.
Zhi X; Department of Respiratory Medicine, Xuanwu Hospital, Capital Medical University, Beijing, China.
Hu M; Department of Thoracic Surgery, Xuanwu Hospital, Capital Medical University, Beijing, China.
He B; Department of Thoracic Surgery, Xuanwu Hospital, Capital Medical University, Beijing, China.

Ther Clin Risk Manag ; 13: 1363-1374, 2017.

Article en En | MEDLINE | ID: mdl-29066904

Palabras clave

biomarkers; cancer monitoring; circulating tumor DNA; ctDNA; liquid biopsy; targeted therapies; tumor heterogeneity

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Screening_studies Idioma: En Revista: Ther Clin Risk Manag Año: 2017 Tipo del documento: Article País de afiliación: China Pais de publicación: Nueva Zelanda

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google